Vested Interests. Influence Muscle. At RFK Jr.’s HHS, It’s Not Pharma. It’s Wellness.
Physician's Weekly
JULY 15, 2025
Kennedy said in April that he was considering a regulatory framework for federal health programs’ coverage of injectable weight loss drugs that would first require patients to try glucose monitoring or other options. Robert Califf, FDA commissioner during the Biden administration, was a consultant to drug companies.
52 
Let's personalize your content